Eli Lilly
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
LLY News
Loading... Loading... Jim Cramer, the host of CNBC’s “Mad Money,” has outlined the key events that investors should keep an eye on in the upcoming week. What...
CNBC's Jim Cramer on Friday walked investors through next week on Wall Street. It's a week jam-packed with notable events, including earnings from Apple , Amazo...
Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures, after a big week for the Nasdaq and leading stocks. X Apple (AAPL),...
Analyst ratings
72%
of 29 ratingsMore LLY News
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy? View comments...
In its upcoming report, Eli Lilly (LLY) is predicted by Wall Street analysts to post quarterly earnings of $2.53 per share, reflecting an increase of 56.2% comp...
For Immediate Release Chicago, IL – April 25, 2024 – Today, Zacks Equity Research discusses Eli Lilly LLY, Novo Nordisk NVO, Merck MRK and AbbVie ABBV. Indust...
In this piece, I evaluated two big pharma stocks, Eli Lilly (NYSE:LLY) and Johnson & Johnson (NYSE:JNJ), using TipRanks’ Comparison Tool below. A closer look su...
Dale Folwell says North Carolina is “under siege” by drugmakers Novo Nordisk and Eli Lilly. The North Carolina treasurer said the sky-high costs of popular wei...
Eli Lilly and Company LLY will report first-quarter 2024 results on Apr 30, before market open. The Zacks Consensus Estimate for this drug giant’s first-quarte...
Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's p...